BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29293188)

  • 1. Weight Gain in Pediatric Acute Lymphoblastic Leukemia Patients With Down Syndrome.
    Hill R; Bricker M; Bashore L; Rapisand S; Heym KM; Hamby T
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):487-488. PubMed ID: 29293188
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.
    Østergaard A; Bohnstedt C; Grell K; Degn M; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Hoogerbrugge P; Schmiegelow K;
    Leukemia; 2021 Mar; 35(3):863-866. PubMed ID: 32623444
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.
    Rabin KR; Smith J; Kozinetz CA
    Pediatr Blood Cancer; 2012 Apr; 58(4):633-5. PubMed ID: 22106003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
    Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbosacral polyradiculopathy after intrathecal chemotherapy in pediatric acute lymphoblastic leukemia.
    Suematsu M; Imamura T; Chiyonobu T; Osone S; Hosoi H
    Int J Hematol; 2018 May; 107(5):499-501. PubMed ID: 29470812
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
    Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction in a young man receiving chemotherapy for acute lymphoblastic leukemia.
    Yang W; Kovacic JC; Cromwell C; Grosskreutz C; Mascarenhas J
    Clin Adv Hematol Oncol; 2013 Oct; 11(10):672-5. PubMed ID: 24518380
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for new thinking: Treatment of relapsed leukemia in children with Down syndrome.
    Rabin K; Izraeli S; Hijiya N; Hitzler J
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27644. PubMed ID: 30724029
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenovirus pneumonia during induction therapy for childhood acute lymphoblastic leukemia.
    Caselli D; Tondo A; Tucci F; Casini T; Paolicchi O; Savelli S; Aricò M
    Pediatr Blood Cancer; 2013 Aug; 60(8):1390-1. PubMed ID: 23630183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
    Indiano JM; Echaniz I; Humayor J; Delgado A
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
    [No Abstract]   [Full Text] [Related]  

  • 14. Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003.
    Furness CL; Kirkwood A; Rowntree C; Vora A; Mitchell C; Samarasinghe S; Goulden N; Moorman A; Hough R
    Br J Haematol; 2019 Feb; 184(4):663-666. PubMed ID: 29468646
    [No Abstract]   [Full Text] [Related]  

  • 15. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
    Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
    Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer.
    Ferster A; Benoit Y; Francotte N; Dresse MF; Uyttebroeck A; Plouvier E; Thyss A; Lutz P; Marguerite G; Behar C; Mazingue F; Boutard P; Millot F; Rialland X; Mechinaud F; Norton L; Robert A; Otten J; Vilmer E; Philippe N; Waterkeyn C; Suciu S
    Blood; 2000 Apr; 95(8):2729-31. PubMed ID: 10809540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of methotrexate in a child with trisomy 21. Value of blood levels].
    Chevallier B; Dessemme P; Flouvat B; Lagardere B
    Ann Pediatr (Paris); 1988 Oct; 35(8):598-9. PubMed ID: 2974271
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcal meningitis during front-line chemotherapy for acute lymphoblastic leukemia.
    Urbini B; Castellini C; Rondelli R; Prete A; Pierinelli S; Pession A
    Haematologica; 2000 Oct; 85(10):1103-4. PubMed ID: 11025610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
    Rumiantseva IuV; Karachunskiĭ AI; Aleĭnikova OV; Fechina LG; Shamardina AV; Litvinov DV; Ponomareva NI; Boĭchenko EG; Dudkin SA; Streneva OV; Kondratchik KL; Mansurova EG; Minkina LM; Lapotentova ES; Iniushkina EV; Iudina NB; Pavlova GP; Zhukovskaia EV; Khlebnikova OP; Lagoĭko SN; Basharova EV; Denisov RE; Zlobina VD; Banshchikova ES; Aslanian KS; Kondakova EV; Tselousova EV; Miakova NV; Turobova TV; Ryskal' OV; Chipsanova NF; Varfolomeeva SR; Rumiantsev AG
    Ter Arkh; 2010; 82(7):11-9. PubMed ID: 20853603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.